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Background: Cardiac rehabilitation (CR), a multidisciplinary program consisting of exercise, risk factor modification
and psychosocial intervention, forms an integral part of managing patients after myocardial infarction (MI),
revascularization surgery and percutaneous coronary interventions, as well as patients with heart failure (HF). This
systematic review seeks to examine the cost-effectiveness of CR for patients with MI or HF and inform policy
makers in Singapore on published cost-effectiveness studies on CR.
Methods: Electronic databases (EMBASE, MEDLINE, NHS EED, PEDro, CINAHL) were searched from inception to May
2010 for published economic studies. Additional references were identified through searching bibliographies of
included studies. Two independent reviewers selected eligible publications based on the inclusion/exclusion criteria.
Quality assessment of economic evaluations was undertaken using Drummond’s checklist.
Results: A total of 22 articles were selected for review. However five articles were further excluded because they
were cost-minimization analyses, whilst one included patients with stroke. Of the final 16 articles, one article
addressed both centre-based cardiac rehabilitation versus no rehabilitation, as well as home-based cardiac
rehabilitation versus no rehabilitation. Therefore, nine studies compared cost-effectiveness between centre-based
supervised CR and no CR; three studies examined that between centre- and home based CR; one between
inpatient and outpatient CR; and four between home-based CR and no CR. These studies were characterized by
differences in the study perspectives, economic study designs and time frames, as well as variability in clinical data
and assumptions made on costs. Overall, the studies suggested that: (1) supervised centre-based CR was highly
cost-effective and the dominant strategy when compared to no CR; (2) home-based CR was no different from
centre-based CR; (3) no difference existed between inpatient and outpatient CR; and (4) home-based programs
were generally cost-saving compared to no CR.
Conclusions: Overall, all the studies supported the implementation of CR for MI and HF. However, comparison
across studies highlighted wide variability of CR program design and delivery. Policy makers need to exercise
caution when generalizing these findings to the Singapore context.Background
Cardiovascular diseases are a major cause of mortality
and morbidity, contributing to about 30% of all-cause
mortality and 10% of the total disability-adjusted life-
years globally [1]. Although advances in medical therapy
and revascularization surgery have improved outcome,
reducing risk factors associated with cardiovascular* Correspondence: WaiPong.Wong@SingaporeTech.edu.sg
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reproduction in any medium, provided the ordiseases remains an important strategy in lowering the
global burden of disease [2]. Risk factor management is
a core component of cardiac rehabilitation, which in
turn forms part of the overall management of patients
with cardiovascular diseases such as coronary artery dis-
ease or chronic heart failure [3,4].
Besides risk factor management (specifically control or
reduction of lipids, blood pressure, body weight, diabetes
mellitus and cigarette smoking), the other core compo-
nents of cardiac rehabilitation include nutritional and
physical activity counseling, psychosocial interventions
and exercise training [4]. In particular, exercise training is
often the component being examined under the umbrellatd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and therefore the cost of the program [5].
Several systematic reviews over the past three decades
have consistently demonstrated cardio-protective effects
of exercise-based cardiac rehabilitation programs [6-9].
Exercise-based cardiac rehabilitation, compared to usual
care, reduces all-cause mortality by 20% (95% confidence
interval, CI: 7%, 32%) and cardiac mortality 26% (95%
CI: 4%, 39%) [8]. Risk factors such as total cholesterol,
triglycerides, systolic blood pressure and self-reported
smoking habits were also significantly reduced [8]. The
pooled sample size for the most recent systematic review
was 8,940, most of whom had undergone at least two
months of cardiac rehabilitation under supervision of
professional exercise personnel [8]. This implies great
involvement of economic cost in the delivery of cardiac
rehabilitation.
Economic evaluation of cardiac rehabilitation has been
reported since the 1980s. A systematic review of eco-
nomic evaluation studies on cardiac rehabilitation, which
identified 15 studies, was reported in 2005. Based on
studies published between 1985 to 2004, supervised car-
diac rehabilitation, compared to usual care, resulted in
USD2,193 to USD28,193 per life year gained, and USD668
to USD16,118 per quality-adjusted life years(monetary
values were 2004 US dollars) [10]. Most of the studies
reviewed up to 2004 were based on prospective rando-
mized controlled trials conducted much earlier than their
published dates. Over the past five years, more economic
evaluation studies emerged. These studies might involve
patients who have undergone more recent medical therap-
ies for coronary artery disease and chronic heart failure.
Recent studies have also focused on comparisons among
different modes of delivery of cardiac rehabilitation, such
as programs that were outpatient-, inpatient- as well as
home-based. Therefore it is timely to systematically re-
view and summarize the evidence on cost-effectiveness of
cardiac rehabilitation.
The overall objective of the current systematic review
was to describe and summarize published economic eva-
luations of cardiac rehabilitation for comparing the cost-
















MI, myocardial infarction; HF, heart failure; CR, cardiac rehabilitation.rehabilitation. The specific aims were to compare the
following modes of delivery:
(a) supervised cardiac rehabilitation versus no cardiac
rehabilitation,
(b) supervised versus home-based cardiac
rehabilitation,
(c) inpatient (not Phase I ward program, but
residential Phase II program) versus outpatient
cardiac rehabilitation, and
(d) home-based cardiac rehabilitation versus no
cardiac rehabilitation.
In this review, cardiac rehabilitation is considered as
consisting of at least exercise training sessions, as this is
usually the component studied as well as being the main
cost driver of cardiac rehabilitation programs.
Methods
Search strategy
Prior to developing the search strategy, “PICO” state-
ments were used to address the specific aims of the sys-
tematic review (Table 1). The electronic databases of
EMBASE, MEDLINE, NHS EED, PEDro and CINAHL
was searched using the text word terms of ‘economic
evaluation’, ‘cost’, ‘cost-effectiveness’, ‘cost-benefit’ or ‘cost-
utility’, and ‘cardiac rehabilitation’ up to May 2010. Hand
searches of bibliographies of each reference followed to
identify any additional publications. Unpublished or grey
literature was not included.
Selection criteria
For the purpose of this review, the inclusion criteria
were as follows:
 Economic evaluation study design that was either
prospective alongside a clinical trial or based on
modeling;
 Adult patients diagnosed with acute myocardial
infarction (including post-infarction and after
revascularization surgery or percutaneous coronary





with acute MI or
chronic HF
Patients diagnosed
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rehabilitation;
 Study with at least one of four comparators listed in
Table 1;
 Outcomes included either cost-effectiveness, cost-
utility or cost-benefit analysis. Cost-minimization
analysis was not included.
Articles were excluded if one of the elements of PICO
(Table 1) was not met.Quality assessment
The 10-item Drummond checklist was used to assess
the methodological quality of the economic evaluation
studies [11]. If the study met any of these 10 items, it
would be considered as ‘Yes’, otherwise ‘No’ or ‘Cannot
tell’ (Additional file 1: Appendix 1). The Drummond
checklist provides a global assessment of the quality of
evidence, but does not form the basis for accepting or
rejecting articles.Data abstraction
Two independent reviewers (JF and WPW) selected
eligible publications initially based on titles and abstracts.
Potentially relevant articles were abstracted using stan-
dardized data abstraction form. This form was also used
for data synthesis. Any disagreement between the
reviewers was resolved by consultation with a third re-
viewer (KHP).Potentially relevant studies 
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Figure 1 Flow of included studies.Results
Synthesis
A total of 896 citations were retrieved based on the
search strategy. Of the 62 articles retrieved for more
detailed evaluation, only 20 were included. An additional
two references from hand searches yielded a total of 22
[12-33] articles for review. Five articles were con-
cerned with cost-minimization analyses, whilst one
article included data from patients with stroke in its eco-
nomic modelling. The remaining 16 articles included one
article that addressed both centre-based cardiac rehabili-
tation versus no rehabilitation, and home-based cardiac
rehabilitation versus no rehabilitation. Among the six
foreign-language articles, three did not meet the inclu-
sion criteria, two were editorials or commentaries and
one was deemed irrelevant after reading through the full
article. Therefore, only 16 articles were included. Figure 1
describes the reasons for not including the articles.
The majority of the articles clearly stated that they
included patients after acute myocardial infarction, follow-
ing revascularization surgery or percutaneous coronary
interventions, or who had a diagnosis of chronic heart
failure, and therefore satisfied the selection criterion on
diagnosis. Two articles employed the same sample for
analyses, involving patients with coronary artery disease,
defined as acute myocardial infarction or angina pectoris
[25,27]. One study included patients with coronary artery
disease, defined as acute myocardial infarction (75% and
79% respectively in both groups) or post-angioplasty
(25% and 21% respectively) [32]. In another study, excluded  
:  
cles were very likely to be irrelevant 
n titles and abstracts (n=835) 
 studies excluded, 
s (n=48) 
Not meeting inclusion criteria (n=33) 
Reviews/editorials/commentaries (n=13) 
Irrelevant after reading the whole paper (n=1) 
Articles using the same datasets and having 
the same conclusions (n=1)
Table 2 Summary of economic evaluations comparing supervised centre-based cardiac rehabilitation (CR) vs no cardiac
rehabilitation (No-CR)
Author (Year) Perspective Patient populations Study type Currency, price year Findings
Levin et al. (1991) Societal N = 305 after MI CCA Swedish kroner, ?year CR: SEK73,500 less per patient
Ades et al. 1992 Patients/ payers N = 580 after MI/CABG CCA US dollars, 1991 CR: $739 less in hospitalization
costs per patient
Oldridge et al. (1993) Societal N = 201 after MI CUA/ modelling US dollars, 1991 CR: $21,800 per life-year
gained; $9,200 per QALY
gained at 1 year
Ades et al. (1997) Patients/ Payers Not applicable Economic modeling US dollars, 1995 CR: $4,950 per year
of life saved
Georgiou et al. (2001) Societal N = 99 with HF CEA US dollars, 1999 ICER= $1,773 per life year
saved in favour of CR
Marchionni et al. (2003) Government
or care providers
N = 158 with MI CCA US dollars, 2000 CR: $21,298 per patient vs
$12,433 per patient in
No-CR group
Yu et al. (2004) Government N= 204 after MI or PCI CUA US dollars, ?year ICUR= $650 per QALY
in favour of CR
Huang et al. (2008) Government N= 4,324 after CABG CEA US dollars, 1998 ICER= 13,887 per year
of life saved
in favour of CR
Dendale et al. (2008) Health care payers N = 213 after PCI CEA Euro, ?year CR: 4,862€ per patient
and 5,498€ per patient
in No-CR group
MI, myocardial infarction. HF, heart failure. CABG, coronary artery bypass graft surgery. PCI, percutaneous coronary intervention. CCA, cost-consequences analysis.
CEA, cost-effectiveness analysis. CUA, cost-utility analysis. QALY, quality-adjusted life-years. ICER, incremental cost-effectiveness ratio. ICUR, incremental cost-utility
ratio.
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39%, chronic heart failure 22%, angina 45%, arrhythimias
59%, and valvular disease 26% [30].
The quality of these articles varied. Articles fulfilled two
to nine items on the Drummond checklist, with none of
them meeting all the items (Additional file 1: Appendix 1).
Table 2 summarizes the economic evaluations reported
in these studies (details in Additional file 2: Appendix 2).
Five of these studies were cost-minimization analysis,
and therefore were strictly not considered as full eco-
nomic evaluations [11].
Supervised (or centre-based) cardiac rehabilitation versus
no cardiac rehabilitation (usual/standard care)
A total of nine studies examined the cost-effectiveness of
supervised centre-based cardiac rehabilitation compared
to no cardiac rehabilitation. Most of the economic stud-
ies were conducted prospectively alongside randomized
controlled trials (RCT) [14,16-18], whilst three studies used
modeling to derive long-term cost-effectiveness [14-16].
All the studies suggested that cardiac rehabilitation super-
vised at a facility compared to no cardiac rehabilitation
was cost-saving [12,13,20], cost-effective [14,17,19] and a
dominant strategy (that is, less cost, more effective)
[16,18]. However, cost-effectiveness could become less
because of escalating medical costs, as demonstrated by
one modeling study [15].Supervised (or centre-based) versus home-based cardiac
rehabilitation
Among 10 studies, six yielded no significant differ-
ences in the clinical outcome measures, and were there-
fore technically considered cost-minimization analyses
[17,21,23,24,28,33]. Of the remaining four studies, one
study employed economic modelling in cost-effectiveness
analysis, using data from patients with cardiovascular
disease, defined as ‘self-report of previous heart attack,
stroke, or other heart disease’ [22]. Among the three
included studies (Table 3), one showed that centre-
based strategy was dominant compared to home-based
rehabilitation [27], whilst two studies demonstrated no
difference in cost-effectiveness [25,26]. In one of the
cost-minimization analyses, cost to the government
(taxation-based health care system) was greater with
home-based program than centre-based program, likely
due to frequent home visits by hospital staff [28]. The
definition of ‘home-based program’ varied among the
three studies, involving combinations of home visits
[25,26] and decreased frequency of centre-based rehabili-
tation attendances [25,27].
Inpatient versus outpatient cardiac rehabilitation
The only study that evaluated cost-effectiveness between
inpatient and outpatient cardiac rehabilitation demon-
strated no significant difference [29] (Table 4).
Table 3 Summary of economic evaluations comparing supervised centre-based cardiac rehabilitation (CR) vs
home-based cardiac rehabilitation (HCR)*
Author (Year) Perspective Patient populations Study type Currency, price year Findings
Reid et al. (2005) Health system N= 392 CAD CCA US dollars, 2004 HCR: $5,267 per patient
CR: $5,132 per patient; no difference
Taylor et al. (2007) Societal N = 80 MI CUA Sterling pounds, 2002-3 ICUR=−£644 per QALY in favour
of CR but not significantly different
Papadakis et al. (2008) Health system N= 392 CAD CUA US dollars, 2004 ICUR= $11,400 per QALY in favour of CR
MI, myocardial infarction. CAD, coronary artery disease. CCA, cost-consequences analysis. CUA, cost-utility analysis. QALY, quality-adjusted life-years. ICUR,
incremental cost-utility ratio. * cost-minimization analyses were not included in this table (refer to Additional file 2: Appendix 2 for details).
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rehabilitation (usual/standard care)
Four studies considered the cost-effectiveness of home-
based program compared to no cardiac rehabilitation
program. Home-based program was considered afford-
able [32] and more cost-effective than no cardiac re-
habilitation [17]. Two studies demonstrated cost-savings
[30,31] with home-based program. Of interest was the
internet-based program by one of these studies [31].
Discussion
This systematic review summarizes the cost-effectiveness
of cardiac rehabilitation compared to no cardiac rehabili-
tation, for patients after myocardial infarction, revasculari-
zation surgery or percutaneous coronary interventions,
as well as those with chronic heart failure. Pooling of
results is not possible given the heterogeneity in per-
spectives, health systems, study designs, details of cardiac
rehabilitation interventions and types of patients that
exist among the studies included in this review. However,
we contend that these studies provide sufficient evidence
for policy development concerning cardiac rehabilitation.
Inclusion of a supervised outpatient cardiac rehabilita-
tion program is clearly more cost-effective than not in-
cluding cardiac rehabilitation program (“usual or standard
care”) into the overall management of patients after myo-
cardial infarction or those with chronic heart failure. The
centre-based programs consisted of exercise-based ses-
sions, three times a week, over a period of 8 to 12 weeks.
In addition, risk factor management and other multi-
disciplinary input were included in half of these studies.
Four of the nine studies were economic evaluations
alongside prospective randomized controlled trials [14,16-
18]. Two of these studies examined cost-effectiveness
from the societal perspective within differing health
systems [14,16]. In the Canadian health system, cardiacTable 4 Summary of economic evaluations comparing superv
supervised centre-based outpatient cardiac rehabilitation (CR
Author (Year) Perspective Patient populations Study typ
Schweikert et al. (2009) Societal N = 147 MI CEA/CUA
MI, myocardial infarction. CEA, cost-effectiveness analysis. CUA, cost-utility analysis.rehabilitation compared to usual care had an incremental
cost-effectiveness of USD9,200 per quality-adjusted life-
year (QALY) gained as well as USD21,800 per life-year
saved (1991 US dollars) at 12 months [14]. In the United
States’ private health care system, cardiac rehabilitation
was the dominant strategy compared to no cardiac re-
habilitation with $1,773 (2001 US dollars) per life-year
saved at 14 months [16]. Recent economic studies with
non-randomized group allocation designs corroborated
this observation, for example, an incremental cost-
effectiveness ratio of $13,887 per life-year saved (1998 US
dollars) was estimated based on Medicare expenditures
for American patients undergoing cardiac rehabilitation;
these patients had concomitant end-stage renal failure re-
quiring haemodialysis and post-coronary artery bypass
graft surgery [19]. In Belgian patients following percutan-
eous coronary interventions, cardiac rehabilitation led to
reduced hospitalization and revascularization surgery, and
subsequently cost (published in 2008, in euros) [20]. One
economic modeling study suggested that cost savings could
become less over the years as a result of rising health care
costs [15]. Much of the cost escalation could be attributed
to the high costs of cardiac investigations and surgery, in
addition to the personnel-intense multidisciplinary cardiac
rehabilitation program [26]. Therefore, home-based pro-
grams have been touted as a cost-effective alternative.
Comparisons between home-based and centre-based
programs were predominantly cost-minimization studies
[17,21,23,24,28,33]. In all these studies, the consequences
of both alternatives were equivalent, so the authors sought
to only compare their costs. Despite different settings,
these studies consistently showed that home- and centre-
based cardiac rehabilitation to be similar in cost.
Although all 13 studies (including cost-minimization
analyses) on home-based cardiac rehabilitation, compared
to either supervised centre-based programs or no cardiacised centre-based inpatient cardiac rehabilitation (ICR) vs
)
e Currency, price year Findings
Euro, 2006 ICER =−165,276€ per QALY in favour of CR,
although no significant
QALY, quality-adjusted life-years. ICER, incremental cost-effectiveness ratio.
Table 5 Summary of economic evaluations comparing home-based cardiac rehabilitation (HCR) and no cardiac
rehabilitation (No-CR)
Author (Year) Perspective Patient populations Study type Currency, price year Findings
Wheeler et al. (2003) Patients/ payers N = 452 women with MI, HF, etc. CCA US dollars, 2000 HCR: 49% lower inpatient cost;
46% fewer inpatient days
Southard et al. (2003) Patients N = 104 MI, CABG, HF CCA/ CBA US dollars, ?year HCR: cost $1,418 less with
213% return on investment
Marchionni et al. (2003) Government
or care providers
N = 153 MI CCA US dollars, 2000 HCR: $13,246 per patient;
better outcomes
No-CR: $12,433 per patient
Salvetti et al. (2008) Health providers N = 39 CAD CCA US dollars, ?year HCR: $502.71 more per patient
MI, myocardial infarction. HF, heart failure. CABG, coronary artery bypass graft surgery. CAD, coronary artery disease. CCA, cost-consequences analysis. CUA,
cost-utility analysis. CBA, cost-benefit analysis.
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be cost-effective or cost-saving, the contents of the home-
based programs varied widely. The contents of home-
based program ranged from actual exercise sessions at
home [21,22,33], frequent home visits by case managers
and physicians [24-26,28], to reduced or more spaced-out
attendances at the centre [17,23,25,27]. Exercise participa-
tion has to be regular to be effective. The option of
reduced or spaced-out attendances at the centre is primar-
ily to encourage the patients to continue with the exercises
at home, whilst providing opportunity to return to the
centre for reinforcement, monitoring and evaluation.
One program was internet-based, requiring computer lit-
eracy, internet access at home and frequent log-ons to
the web site to update on completion of exercises [31].
Early studies (before 2005) tended to demonstrate that
home-based programs were more cost-effective and cost-
saving than centre-based ones [17,21-24,33]. Sensitivity
analyses in some of these studies have shown no change
to the conclusion despite taking the worst-case scenario
[17] or varying variables such as costs [24], readmission
rates [24], patients’ travelling time [24], exercise adherence
[22] and discounting rates [22,24]. Home-based pro-
grams in these studies were varied, including program
with reduced sessions at the centre to exercise program
conducted entirely at home with or without frequent
home visits by health care professionals (see Table 3).
However, the recent studies have shown otherwise
[25-28]. Three recent studies demonstrated no significant
difference in the cost-effectiveness of centre- versus
home-based programs [25,26,28]. In one study, sensitivity
analyses by taking the upper estimate of UK hospital
rehabilitation costs did not alter the conclusion, because
cardiac-related costs far exceeded rehabilitation costs
[26]. All three economic evaluations were conducted
alongside randomized controlled trials, within a taxation-
based health care system (Canada and UK) and involved
multiple home visits by health care professionals (case
managers, physicians and rehab nurses). One recent study
demonstrated greater quality adjusted life-year gainedamong participants in centre-based program than those
in home-based program [27]. The “home-based” program
in this study was 33 cardiac rehabilitation sessions spread
across 12 months, whereas the centre-based program was
the same 33 sessions conducted over 3 months. Interest-
ingly, these authors found that the spread-out program
was more cost-effective among women whilst the centre-
based program was more cost-effective among men [27].
Thus, the cost-effectiveness of the so-called home-based
cardiac rehabilitation program depends heavily upon its
contents as well as patient profiles. Policy decision makers,
and payers or purchasers of cardiac rehabilitation services,
should take into consideration of the model of home-
based programs when considering resource allocation.
The use of information and communication technology
and internet-based programs should be explored, and
therefore further studies could compare internet- versus
centre-based programs in terms of cost-effectiveness.
Limitations
None of the 16 articles met all of Drummond’s 10-item
checklist (Table 2). Articles were dated as early as 1985
and as recently as 2009, with 13 of the articles published
in the last 10 years. Majority of the studies collected and
analyzed only direct medical costs. Few studies considered
sensitivity analysis to account for uncertainty in costs
and consequences. Although none of the foreign-language
articles were included, none met the inclusion criteria for
review. Publication bias cannot be excluded as almost all
the economic evaluations demonstrated cost-effectiveness.
Conclusions
In conclusion, evidence exists that supports the inclusion
of supervised outpatient centre-based or home-based
cardiac rehabilitation compared to no cardiac rehabilita-
tion in patients after myocardial infarction, revasculariza-
tion surgery or percutaneous coronary interventions, as
well as those with chronic heart failure. Based on the
reviewed articles, it would appear that the costs and out-
comes of home- versus supervised centre-based cardiac
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the mode of delivery (home- versus centre-based) should
be left to purchasers and patients. To the policy decision
makers, there could be possible economic advantage of
home-based program over centre-based ones. However,
the details of what constitute “home-based program” are
important.
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